Saba Capital Reduces Stake in BlackRock ESG Capital Allocation Term Trust with $11.75M in Sales
ECAT sits 16% above its 52-week low of $13.35.
Summary
Activist investor Saba Capital Management reported selling approximately $11.75 million worth of shares in BlackRock ESG Capital Allocation Term Trust, reducing its overall stake.
Key Events · Ownership and Investor Activity · ECAT
-
Activist Investor Reduces Stake
Saba Capital Management, L.P. and its affiliates reported a reduction in their beneficial ownership, now holding 25,798,288 common shares, representing 25.97% of the class.
-
Significant Open Market Sales
Between November 25, 2025, and January 21, 2026, Saba Capital executed open market sales totaling approximately $11.75 million. Additionally, 334,659 shares were disposed of via a pro-rata distribution in-kind for no consideration.
Analysis · ECAT · Unknown
Saba Capital Management, a known activist investor, has significantly reduced its stake in BlackRock ESG Capital Allocation Term Trust through open market sales totaling approximately $11.75 million. While the firm still holds a substantial 25.97% of the company's common shares, this reduction signals a potential shift in their investment thesis or a move to rebalance their portfolio. Investors should monitor future filings for further changes in Saba Capital's position, as continued selling could indicate a lack of confidence or a winding down of their activist campaign.
At the time of this filing, ECAT was trading at $15.50 on NYSE in the Unknown sector. The 52-week trading range was $13.35 to $17.16. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.